Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ahead of an exhibition at Oxford's Museum of Natural History, Professor Rebeccah Slater from the Department of Paediatrics explains how she became interested in the area of pain in babies and pre-term babies.

A new exhibition at Oxford’s Museum of Natural History in partnership with Oxford Neuroscience, opens on 10 March 2017. ‘Brain Diaries’ charts the astonishing development of the human brain, from conception through childhood and adulthood to old age.

Professor Rebeccah Slater is taking part in the launch of this celebration and exploration of the work of Oxford's thriving community of neuroscientists.

Here she talks about her work, and her hopes for how the research will offer better and more targeted pain relief in infants.

Read more (Department of Paediatrics website) 

Similar stories

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Clinical Trials Coronavirus COVID-19 General Research

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).